OCTOBER 2, 2024 — 231 NEW JERSEY EMPLOYEES
The company announced plans to lay off 231 employees in New Brunswick, New Jersey effective December 27, 2024.
A company spokesperson noted, “Johnson & Johnson is tackling the world’s toughest health challenges through science and technology-driven innovation. To continue to meet the needs of patients around the world today and for years to come, we must adapt and evolve our businesses in the midst of a complex and rapidly changing external environment. Guided by our credo, we will support employees who are affected by these changes, helping them explore new options within the company and providing access to career services and related support.”
MARCH 6, 2023 — 1,000+ EMPLOYEES TARGETED FOR LAYOFFS
The company has announced a restructuring of its MedTech business following a “comprehensive review” of its portfolio. The restructuring is expected to impact 1000+ employees as operations are combined to create operational efficiencies.
OCTOBER 21, 2022 — 64 EMPLOYEES IN NEW YORK
The company has announced plans to lay off 64 employees in its Johnson & Johnson Services office in Manhattan in phases between January 13, 2023, and January 26, 2023.
NOVEMBER 13, 2021 — J&J TO SPLIT INTO 2 COMPANIES WITH UNKNOWN CONSEQUENCES TO EMPLOYEES
The company has announced that it will split into two publicly traded companies that “will make each business more nimble in adapting to their respective markets. It also allows for a more precise allocation of capital.”
The company said it will separate its consumer health business segment that sells Band-Aids, Listerine, and over-the-counter medicines like Tylenol from its pharmaceutical and medical device business.
According to J&J CEO Alex Gorsky, “We’ve seen a significant evolution in these markets, particularly on the consumer side,”
The segment selling prescription drugs and medical devices — J&J’s two largest businesses — will keep the Johnson & Johnson name. Its products include the cancer treatment Darzalex, a COVID-19 vaccine, and medical devices for orthopedics and surgery.
The new consumer health company has yet to be named. It will house brands including Neutrogena, Aveeno, and the iconic Band-Aids, which a company employee created more than 100 years ago.
APRIL 7, 2021 — Original post…
New Brunswick, New Jersey-based Johnson & Johnso, a developer of medical devices, pharmaceuticals, and consumer products, has announced that it will be permanently closing its South San Francisco, California multi-division offices and relocating some functions to Titusville, New Jersey.
The closure will affect 73 employees with Actelion Pharmaceuticals US Inc. (36 employees including marketing, administrative and medical, and scientific affairs positions); Johnson & Johnson Health Care Systems Inc.(5 employees); Janssen Scientific Affairs LLC (11 employees); Janssen Pharmaceuticals Inc. (8 employees); Johnson & Johnson International (6 employees); Johnson & Johnson Services Inc. (3 employees); Janssen Global Services Inc. (2 employees); and Johnson & Johnson 2 employees).
According to a company statement, "We are relocating our U.S. Pulmonary Hypertension home office from San Francisco, CA to Titusville, New Jersey to integrate our Pulmonary Hypertension business with the rest of our Janssen therapeutic areas, foster closer collaboration, drive growth and innovation, and broaden career opportunities for our team members. We are not eliminating any jobs as part of this transition. All employees whose roles are in scope have the option to relocate, and Janssen will provide assistance and cover relocation costs for employees who choose to move to the East Coast.”
Change is coming. There will always be a tomorrow, no matter how much you may try to ignore it. There are no guarantees in life or promises for a bright future. Just because something bad hasn't happened yet, doesn't mean it won't. It can happen to anyone, anytime, anywhere. No one is guaranteed to wake up tomorrow and still have a job by evening. Are you now wondering, Am I Next?